Woodline Partners LP Uro Gen Pharma Ltd. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Woodline Partners LP holds 305,642 shares of URGN stock, worth $3.64 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
305,642
Previous 305,642
-0.0%
Holding current value
$3.64 Million
Previous $3.88 Million
16.13%
% of portfolio
0.02%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
136Shares Held
36MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$45.6 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$34.8 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$27.4 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$26.1 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$20.8 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $271M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...